Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence

Miehlke, et al. Ther Adv Gastroenterol (2020), Vol. 13: 1–15

RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis

Hirano, et al. Gastroenterology 2019;156:592–603

Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial

Lucendo, et al. Gastroenterology 2019;157:74–86

A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis

Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies

Arias, et al. Aliment Pharmacol Ther 2016; 43: 3–15 5

Meta-Analysis-Based Guidance for Dietary Management in Eosinophilic Esophagitis

Lucendo. Curr Gastroenterol Rep (2015) 17:37. Springer

Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients With Symptomatic Esophageal Eosinophilia: A Systematic Review and Meta-Analysis

Lucendo, et al. Clinical Gastroenterology and Hepatology 2016;14:13–22

Role of endoscopic esophageal dilation in managing eosinophilic esophagitis

Moole, et al. Medicine (2017) 96:14

Esophageal dilation with either bougie or balloon technique as a treatment for eosinophilic esophagitis: a systematic review and meta-analysis

Dougherty, et al. Gastrointest Endosc. 2017 October ; 86(4): 581–591

Systematic review with meta-analysis: endoscopic dilation is highly effective and safe in children and adults with eosinophilic oesophagitis

Moawad, et al. Aliment Pharmacol Ther. 2017;46:96–105